SCHEMBL20249669

SCHEMBL20249669

Cc1c2c(-c3cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)nc3ccccc3c2c(C)c2c(-c3ccccc3)nc3ccccc3c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ATM Q13315 1/20 0.46
PDE10A Q9Y233 3/20 0.44
TSHR P16473 2/20 0.44
NR1I3 Q14994 3/20 0.44
WHR1 P49842 1/20 0.43
DHODH Q02127 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
ABCB1 P08183 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C9 P11712 3/20 0.41
HSD17B10 Q99714 3/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20245165 0.92 MEN1 (0.45) MEN1KMT2AATMPDE10ATSHR
SCHEMBL20249706 0.91 ATM (0.54) MEN1KMT2AATMPDE10ATSHR
SCHEMBL20249646 0.90 MEN1 (0.48) MEN1KMT2AATMPDE10ATSHR
SCHEMBL20249701 0.87 ABCG2 (0.41) MEN1KMT2AATMTSHRDHODH
SCHEMBL20245131 0.87 MAPT (0.42) MEN1KMT2AATMWHR1DHODH
SCHEMBL20249691 0.86 DHODH (0.47) MEN1KMT2AATMPDE10ATSHR
SCHEMBL20249671 0.84 MEN1 (0.40) MEN1KMT2AATMPDE10ATSHR
SCHEMBL20249698 0.84 ABCG2 (0.44) MEN1KMT2AATMWHR1DHODH
SCHEMBL20249700 0.84 MEN1 (0.44) MEN1KMT2AATMWHR1DHODH
SCHEMBL20245170 0.84 CYP1A2 (0.47) MEN1KMT2AATMTSHRABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3333168-B1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-01-26 EP disclosed
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 394/4885KMT2A 1848/4885ATM 1159/4885
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MEN1 394/4885KMT2A 1848/4885ATM 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.